Search results
Lisa Evans DeWald 1 , Chloe Starr 1 , Terry Butters 2 , Anthony Treston 1 , Kelly L Warfield 3. Affiliations. 1 Emergent BioSolutions, Gaithersburg, MD, 20879, USA. 2 Oxford Glycobiology Institute, Oxford, OX1 3QU, UK. 3 Emergent BioSolutions, Gaithersburg, MD, 20879, USA. Electronic address: WarfieldK@ebsi.com. PMID: 32768411.
- Lisa Evans DeWald, Chloe Starr, Terry Butters, Anthony Treston, Kelly L. Warfield
- 2020
View full-text. Lisa Evans DeWald's 34 research works with 1,030 citations and 5,431 reads, including: Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals...
Nov 22, 2018 · Bepridil, a calcium channel blocker developed for treating angina, was identified as a potent inhibitor of filoviruses in vitro, including Ebola and Marburg viruses, and Ebola virus in vivo. We evaluated the efficacy of bepridil in a lethal mouse model of Marburg virus disease.
- Lisa Evans DeWald, Julie Dyall, Jennifer M Sword, Lisa Torzewski, Huanying Zhou, Elena Postnikova, E...
- 2018
U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Frederick, MD 21702, USA.
Semantic Scholar profile for Lisa Evans DeWald, with 41 highly influential citations and 19 scientific research papers.
Aug 1, 2020 · Content may be subject to copyright. Journal Pre-proof. Iminosugars: a host-targeted approach to combat Flaviviridae infections. Lisa Evans DeWald, Chloe Starr, Terry Butters, Anthony...
Jul 4, 2018 · Lisa Evans DeWald, J. Dyall, +13 authors. P. Jahrling. Published in Journal of Infectious… 4 July 2018. Medicine. TLDR. Bepridil's broad-spectrum anti-filovirus activity warranting further investigation of bepridil, or improved compounds with a similar mechanism, as a pan-Filovirus therapeutic agent is confirmed. Expand. View on PubMed.
